Mammoth Biosciences

Mammoth Biosciences is a biotechnology company focused on leveraging proprietary ultracompact CRISPR systems to develop long-term curative therapies and decentralized precision diagnostics. The company develops in vivo gene editing therapeutics using base editing, gene writing, and epigenetic editing modalities, and partners with leading pharmaceutical and biotechnology companies to broaden the reach of its technology.